Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

680
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
680
Learning Disabilities01:25

Learning Disabilities

580
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
580
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

1.0K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haptoglobin, hemolysis, and renal vulnerability after pulsed field ablation: The hemoglobin-binding reserve.

Heart rhythm·2026
Same author

Haptoglobin Phenotype and Cardiovascular Risk: The ACCORD Blood Pressure RCT.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Rescue of <i>Iqsec2</i> Knockout Mice with Human IQSEC2 Adeno-Associated Virus Mediated Gene Therapy.

International journal of molecular sciences·2025
Same author

Cryo-EM structure of AAA + ATPase thorase reveals novel helical filament formation.

Computational and structural biotechnology journal·2025
Same author

Structural and Functional Analysis of the Human IQSEC2 S1474Qfs*133 Mutation.

Biomolecules·2025
Same author

Relationship between time-varying achieved HbA<sub>1c</sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study.

BMJ open diabetes research & care·2025

Related Experiment Video

Updated: Jan 23, 2026

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

25.7K

IQSEC2-Associated Intellectual Disability and Autism.

Nina S Levy1, George K E Umanah2, Eli J Rogers3

  • 1Technion Israel Institute of Technology, 1 Efron St., Haifa, 3525422, Israel. ninal@technion.ac.il.

International Journal of Molecular Sciences
|June 26, 2019
PubMed
Summary

Mutations in IQSEC2 gene are linked to intellectual disability and autism. This study reviews how IQSEC2 signaling impacts neuronal function and suggests therapeutic targets for related conditions.

Keywords:
AMPA receptorsNMDA receptorsautismguanine nucleotide exchange factorintellectual disabilitysynaptic plasticity

More Related Videos

Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities
09:38

Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities

Published on: January 29, 2014

11.2K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.5K

Related Experiment Videos

Last Updated: Jan 23, 2026

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

25.7K
Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities
09:38

Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities

Published on: January 29, 2014

11.2K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the IQSEC2 gene are a known cause of intellectual disability (ID), often presenting with seizures and autism spectrum disorder.
  • IQSEC2 is crucial for neuronal development and synaptic plasticity, particularly within excitatory synapses.
  • Dysregulation of synaptic proteins, including NMDA and AMPA receptors, is implicated in the pathophysiology of autism.

Purpose of the Study:

  • To review the signaling pathways of neuronal IQSEC2, focusing on its role in autism.
  • To elucidate the molecular mechanisms by which IQSEC2 influences synaptic function.
  • To identify potential therapeutic targets for IQSEC2-associated ID and autism.

Main Methods:

  • Review of existing literature on IQSEC2 signaling and its interaction with synaptic proteins.
  • Analysis of the molecular cascade involving NMDA receptor activation, calcium/calmodulin binding, and ARF6 activation.
  • Examination of data from an IQSEC2 transgenic mouse model exhibiting autistic features.

Main Results:

  • IQSEC2 interacts with NMDA receptors via PSD-95, and its activation leads to ARF6 activation.
  • Activated ARF6, through a JNK-mediated pathway, downregulates surface AMPA receptors.
  • An IQSEC2 mutation (A350V) in mice resulted in autistic behaviors and decreased surface GluA2 levels.

Conclusions:

  • IQSEC2 signaling critically regulates the surface expression of AMPA receptors, a process disrupted in autism.
  • Sec7 activity and AMPA receptor recycling represent promising therapeutic targets for IQSEC2-related neurological disorders.